The association between diabetes related medical costs and glycemic control: A retrospective analysis
2006

Diabetes Costs and Glycemic Control

Sample size: 10780 publication Evidence: high

Author Information

Author(s): Oglesby Alan K, Secnik Kristina, Barron John, Al-Zakwani Ibrahim, Lage Maureen J

Primary Institution: Eli Lilly and Company

Hypothesis

Lower glycemic control would be significantly associated with lower direct medical costs.

Conclusion

Direct medical costs of treating type 2 diabetes are significantly higher for individuals with fair or poor glycemic control than for those with good glycemic control.

Supporting Evidence

  • 42.1% of those treated only with oral agents had suboptimal control.
  • 66.1% of those treated with oral agents and insulin had suboptimal control.
  • 57.2% of those treated with insulin alone had suboptimal control.
  • Direct medical costs were 16% lower for individuals with good glycemic control than for those with fair control.
  • Direct medical costs were 20% lower for individuals with good glycemic control than for those with poor control.
  • Prescription drug costs were significantly lower for individuals with good glycemic control compared to those with fair or poor control.

Takeaway

If you keep your blood sugar levels good, you spend less money on diabetes treatments. If your blood sugar is not good, you spend more.

Methodology

A longitudinal analysis using a large health plan administrative database was performed, including individuals diagnosed with type 2 diabetes who had at least two HbA1c values post diagnosis.

Potential Biases

The reliance on a claims database means individuals could not be definitively classified as having type 2 diabetes.

Limitations

The study's results may not be generalizable to other populations and did not capture patients' exposure to diet and exercise.

Participant Demographics

Average age was approximately 63 years, with 53% males and predominantly Medicare insured (54%).

Statistical Information

Confidence Interval

$1,505 ($1,441 – $1,571) for good control; $1,801 ($1,674 – $1,937) for fair control; $1,871 ($1,684 – $2,078) for poor control.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1478-7547-4-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication